Skip to main content

Early Detection

Advances research to determine the effectiveness and clinical impact – harms and benefits – of cancer early detection technologies and practices, including imaging and molecular biomarker approaches. Fosters technological development, statistical modeling, and dissemination of scientific findings to promote early cancer detection practices.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Resources

Cancer Data Access System (CDAS)

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	LeeVan, Elyse, M.D., M.P.H. elyse.leevan@nih.gov 240-276-7314	5E110	Program Officer \| Early Detection
	McCarty, Larae larae.mccarty@nih.gov 240-276-5777	5E322	Program Specialist \| Community Oncology and Prevention Trials Early Detection
	Miller, Eric, Ph.D. eric.miller2@nih.gov 240-276-5336	5E212	Program Officer \| Early Detection
	Ong, Mary Jane maryjane.ong@nih.gov 240-858-3296	5E120	Nurse Consultant \| Early Detection
	Pinsky, Paul, Ph.D. paul.pinsky@nih.gov 240-276-7014	5E108	Chief \| Early Detection
	Saxena, Neeraj, Ph.D. neeraj.saxena@nih.gov 240-276-6302	5E218	Program Officer \| Early Detection
	Zhu, Claire, Ph.D. claire.zhu@nih.gov 240-276-7013	5E106	Program Officer \| Early Detection

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Wang, Kai	Massachusetts General Hospital United States	Dietary prevention for colorectal cancer: targeting the bile acid/gut microbiome axis	4R00CA283146-03	Amit Kumar, Ph.D.
Warner, Erica T	Massachusetts General Hospital United States	Aspirins legacy on cancer and overall benefit: risk balance over a 15-year horizon	3U01CA301988-02S1	Asad Umar, D.V.M., Ph.D.
Washington, Karla	Washington University United States	Problem-Solving Therapy for Cancer Caregivers: A Randomized Clinical Trial in Outpatient Palliative Care	5R01CA258311-05	Brennan Streck, Ph.D., RN, M.P.H.
Watt, Gordon Patrick	Netherlands Cancer Institute United States	Quantitative background parenchymal enhancement, measured on contrast-enhanced mammogram, as a novel marker of breast cancer risk	3R37CA284134-03S1	Claire Zhu, Ph.D.
Webster, Nicholas J	University Of California, San Diego United States	Time-restricted feeding and breast cancer	5R01CA196853-09	Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Webster, Nicholas J	Veterans Medical Research Fdn/San Diego United States	The Effect of Time-Restricted Eating on the Efficiency of Chemo- and Hormonal-Therapy in Breast Cancer	5R21CA288777-02	Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Wei, Lei	Roswell Park Cancer Institute Corp United States	Advancing skin cancer prevention by tackling UV-induced clonogenic mutations	5R01CA255242-05	Wendy Wang, Ph.D., M.Sc.
Welsh, Joellen	State University Of New York At Albany United States	Vitamin K: Body Pools and Function in Breast Cancer	5R01CA258231-05	Young Kim, Ph.D.
Whitman, Eric	Atlantic Health System, Inc. United States	The Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC Corp)	3UG1CA239772-06S1	Vanessa A. White, M.P.H.
Wildman-Tobriner, Benjamin	Duke University United States	AI for Differentiation of Low vs High Risk Thyroid Nodules on Ultrasound	1R01CA297227-01A1	Wendy Wang, Ph.D., M.Sc.
Wilkin, Timothy J.	University Of California, San Diego United States	Partnership for advancing cervical cancer prevention in women living with HIV (CASCADE - Research Hub)	5UG1CA275414-05	Maria Silvina Frech, Ph.D., M.S.
Williams, Paige L	Harvard University D/B/A Harvard School Of Public Health United States	Pediatric HIV/AIDS Cohort Study (PHACS) 2020	3P01HD103133-05S1	Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Winer, Rachel L.	University Of Washington United States	The CASCADE CLIMB: Cervical cancer prevention in women Living with HIV research Mobilization Base	5UG1CA275402-04	Maria Silvina Frech, Ph.D., M.S.
Winger, Joseph Giles	Duke University United States	Engage: A Randomized Controlled Trial Testing the Efficacy of a Telehealth-Delivered Psychosocial Intervention to Decrease Symptom Interference in Patients with Advanced Cancer	5R01CA291768-02	Brennan Streck, Ph.D., RN, M.P.H.
Winters-Stone, Kerri M	Oregon Health & Science University United States	Patterns and predictors of symptoms, falls, and functioning across treatment and recovery in patients treated with neurotoxic chemotherapy for cancer	5R01CA248059-05	Goli Samimi, Ph.D., M.P.H.